{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:00:21Z","timestamp":1784314821358,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,13]]},"DOI":"10.7759\/cureus.58166","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T08:14:56Z","timestamp":1712996096000},"source":"Crossref","is-referenced-by-count":1,"title":["High-Grade Atrioventricular Block Reveals Rare Transthyretin Cardiac Amyloidosis With Unique Hemodynamics"],"prefix":"10.7759","author":[{"given":"Zeyad J","family":"Rifai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad H","family":"Sukkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samie","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Transthyretin amyloid cardiomyopathy (ATTR-CM)","author":"Jain A","year":"2024","unstructured":"Jain A, Zahra F. Transthyretin amyloid cardiomyopathy (ATTR-CM). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi C","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC, et al.. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009, 120:1203-12. 10.1161\/CIRCULATIONAHA.108.843334","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2020.05.021","article-title":"Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis","volume":"128","author":"Donnellan E","year":"2020","unstructured":"Donnellan E, Wazni OM, Saliba WI, et al.. Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis. Am J Cardiol. 2020, 128:140-6. 10.1016\/j.amjcard.2020.05.021","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.133","article-title":"Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs","volume":"410","author":"Bourgault S","year":"2011","unstructured":"Bourgault S, Choi S, Buxbaum JN, Kelly JW, Price JL, Reixach N. Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs. Biochem Biophys Res Commun. 2011, 410:707-13. 10.1016\/j.bbrc.2011.04.133","journal-title":"Biochem Biophys Res Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer MS","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, et al.. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018, 379:1007-16. 10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeab226","article-title":"Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy","volume":"23","author":"Rettl R","year":"2022","unstructured":"Rettl R, Mann C, Duca F, et al.. Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022, 23:767-80. 10.1093\/ehjci\/jeab226","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref8","article-title":"Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG","volume":"36","author":"Nakata T","year":"1995","unstructured":"Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, Iimura O. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med. 1995, 36:1040-2.","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1769059","article-title":"Cardiac sympathetic denervation in wild-type transthyretin amyloidosis","volume":"27","author":"Gimelli A","year":"2020","unstructured":"Gimelli A, Aimo A, Vergaro G, et al.. Cardiac sympathetic denervation in wild-type transthyretin amyloidosis. Amyloid. 2020, 27:237-43. 10.1080\/13506129.2020.1769059","journal-title":"Amyloid"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution","volume":"14","author":"Poterucha TJ","year":"2021","unstructured":"Poterucha TJ, Elias P, Bokhari S, et al.. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution. JACC Cardiovasc Imaging. 2021, 14:1221-31. 10.1016\/j.jcmg.2020.08.027","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/236675-high-grade-atrioventricular-block-reveals-rare-transthyretin-cardiac-amyloidosis-with-unique-hemodynamics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T08:15:00Z","timestamp":1712996100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/236675-high-grade-atrioventricular-block-reveals-rare-transthyretin-cardiac-amyloidosis-with-unique-hemodynamics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.58166","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,13]]}}}